Global Point of Care
Home > Products

Panbio™ COVID-19/Flu A&B Rapid Panel (Nasopharyngeal)

DIFFERENTIAL DIAGNOSIS ENABLES TIMELY TREATMENT DECISIONS

COVID-19 and Influenza have similar symptoms, making differential diagnosis difficult. Using one nasopharyngeal swab, the Panbio™ COVID-19/Flu A&B Rapid Panel simultaneously tests for COVID-19, Influenza A, and Influenza B, with results in 15 minutes. Ideal for testing many people quickly in general practice offices, point-of-care sites, workplaces, pharmacies, and schools/universities. Make actionable decisions quickly to help prevent the spread of illness.

Product not available in all countries. Not approved for sale in the USA.

Benefits
  • Differential diagnosis allows rapid, targeted treatment decisions
  • Quickly identify contagious people so treatment or isolation decisions can be made
  • Easily deploy in large scale, high-throughput testing programs
  • For patients presenting symptoms or suspected of current COVID-19 and Flu A or B infection
  • 1 nasopharyngeal swab sample for both COVID-19 and Flu A&B
Helpful Documents
  • Results in 15 minutes
  • Nasopharyngeal swab
  • Pre-filled buffer extraction tubes
  • Positive Controls available (sold separately)
  • Storage: 2°C–30°C
  • 10 Test Kit Contents:
    - 10 Test devices
    - 10 Extraction buffer tubes
    - 10 Nozzle caps
    - 10 Sterilized nasopharyngeal swabs for specimen collection
    - 1 Tube rack
    - 1 Instructions for Use with Quick Reference Guide
  • Positive Controls Kit Contents:
    - 10 Positive Control Swabs
    - 1 Instructions for Use with Quick Reference Guide
  • CE Mark
Product Codes Code
Panbio™ COVID-19/Flu A&B Rapid Panel (Nasopharyngeal) 10 test kit 62FK10
Positive Controls for Panbio™ COVID-19/Flu A&B Rapid Panel 62FK11C

Stay informed

Sign up to receive valuable updates from Abbott.